Indraprastha Medical Corporation Ltd

NSE: INDRAMEDCO BSE: 532150

₹321.45

-6.35 (1.94%)

Sat, 24 Oct 2026, 07:55 am

MTF 5xInvest in Indraprastha Medical Corporation Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)3008.25

PE Ratio15.67

Dividend1.22

Health Services

Hospital/Nursing Management

24.5K

Indraprastha Medical Corporation Ratios

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Price to earnings ratio	19.73	17.64	17.67	10.71	13.38	10.15	12.02	10.43	10.04	15.71	19.46	18.55	20.98	12.37	7.13	211.53	9.14	8.27	12.70	21.98
Price to book ratio	2.94	2.30	2.50	2.10	3.06	2.09	2.03	1.76	1.90	2.62	2.13	2.11	1.91	1.44	1.16	1.81	1.65	1.88	3.30	5.93
Price to sales ratio	1.61	1.12	0.91	0.65	0.98	0.72	0.64	0.50	0.54	0.73	0.63	0.65	0.60	0.45	0.38	0.80	0.60	0.65	1.26	2.61
Price to cash flow ratio	12.91	15.41	5.64	4.60	5.90	9.04	6.10	4.74	6.76	8.39	7.87	17.63	9.50	4.78	3.66	17.67	7.32	4.66	7.45	20.71
Enterprise value	375Cr	308Cr	347Cr	302Cr	441Cr	381Cr	387Cr	369Cr	413Cr	554Cr	522Cr	547Cr	500Cr	350Cr	301Cr	473Cr	473Cr	586Cr	1384Cr	3250Cr
Enterprise value to EBITDA ratio	18.99	16.21	16.58	6.47	7.38	7.55	7.96	4.92	5.41	8.22	6.60	8.02	7.51	4.78	3.82	11.32	3.92	3.85	7.07	13.15
Debt to equity ratio	0.44	0.47	0.57	0.40	0.22	0.50	0.42	0.43	0.34	0.26	0.23	0.29	0.28	0.09	0.05	0.03	0.02	0.01	0.07	0.05
Return on equity %	0	13.06	14.20	20.26	24.12	21.56	17.50	17.42	19.79	17.02	11.68	11.55	9.11	11.93	17.05	0.86	19.60	24.44	28.92	29.97

Indraprastha Medical Corporation Ltd Ratios

The Indraprastha Medical Corporation Ltd Ratios page provides a complete fundamental analysis of Indraprastha Medical Corporation Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Indraprastha Medical Corporation Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Indraprastha Medical Corporation Ltd (NSE: INDRAMEDCO, BSE: 532150) is currently trading at ₹321.45, with a market capitalization of ₹3008.25Cr. As a major player in the Health services sector and Hospital/Nursing management industry, Indraprastha Medical Corporation Ltd remains a key stock for fundamental analysis using Indraprastha Medical Corporation Ltd Ratios.

Indraprastha Medical Corporation Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Indraprastha Medical Corporation Ltd P/E ratio currently stands at 21.98, making it one of the most tracked metrics in Indraprastha Medical Corporation Ltd Ratios.

Historically, the Indraprastha Medical Corporation Ltd P/E ratio has shown strong fluctuations:

2025: 21.98
2024: 12.70
2023: 8.27
2022: 9.14
2021: 211.53

The rising Indraprastha Medical Corporation Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Indraprastha Medical Corporation Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.93.

Historical P/B trend:

2025: 5.93
2024: 3.30
2023: 1.88
2022: 1.65

Indraprastha Medical Corporation Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Indraprastha Medical Corporation Ltd P/S ratio currently stands at 2.61, an important part of Indraprastha Medical Corporation Ltd Ratios for revenue valuation.

Historical P/S ratio:

2025: 2.61
2024: 1.26
2023: 0.65
2022: 0.60

The rising Indraprastha Medical Corporation Ltd P/S ratio indicates improved revenue valuation by investors.

Indraprastha Medical Corporation Ltd Price to Cash Flow Ratio (P/CF)

The Indraprastha Medical Corporation Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 20.71.

Historical Indraprastha Medical Corporation Ltd Price to Cash Flow Ratio:

2025: 20.71
2024: 7.45
2023: 4.66
2022: 7.32
2021: 17.67

The rising Indraprastha Medical Corporation Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Indraprastha Medical Corporation Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Indraprastha Medical Corporation Ltd EV currently stands at ₹3250Cr, representing the total company valuation including debt.

Historical EV trend:

2025: 3250Cr
2024: 1384Cr
2023: 586Cr
2022: 473Cr

Indraprastha Medical Corporation Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Indraprastha Medical Corporation Ltd EV/EBITDA ratio is currently 13.15, a key metric in Indraprastha Medical Corporation Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

2025: 13.15
2024: 7.07
2023: 3.85
2022: 3.92

Higher Indraprastha Medical Corporation Ltd EV/EBITDA suggests premium valuation.

Indraprastha Medical Corporation Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Indraprastha Medical Corporation Ltd D/E ratio is currently 0.05, reflecting leverage and financial stability.

Historical D/E:

2025: 0.05
2024: 0.07
2023: 0.01
2022: 0.02

Indraprastha Medical Corporation Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Indraprastha Medical Corporation Ltd ROE currently stands at 29.97%, showing profitability and capital efficiency.

Historical ROE:

2025: 29.97
2024: 28.92
2023: 24.44
2022: 19.60

Indraprastha Medical Corporation Ltd demonstrates strong profitability and efficient capital utilization.

Indraprastha Medical Corporation Ltd Ratios Analysis Summary

The Indraprastha Medical Corporation Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Indraprastha Medical Corporation Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Indraprastha Medical Corporation Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.